CBD is the major non-euphorigenic component of Cannabis sativa. Some research is beginning to show that CBD is different than other well-studied cannabinoids. All cannabinoids function as ligands, meaning they dock onto the binding site of a protein and have the ability to modulate a receptor’s behavior. CB1 receptors are widely distributed, but are particularly abundant in areas of the brain, including those concerned with movement, coordination, sensory perception, emotion, memory, cognition, autonomic and endocrine functions.
Read the label to find out the total milligrams of CBD in the entire bottle/product and how many milligrams are in one standard dose. CBD products vary in potency, with some containing more total CBD than others. Most products will have on the label exactly how much CBD is in one dropper or drop, so you’ll be able to tell exactly how much is in there.
THC is found in large quantities in cannabis, or what most people think of as the marijuana plant. Unlike cannabis, or marijuana, hemp contains low concentrations of THC. CBD Oils are generally made from the hemp plant so they contain high levels of CBD and trace levels of THC. As a result, CBD provides a less controversial alternative to THC for health benefits.
These trichomes are tiny, hair-like crystals that cover the leaves and buds of the cannabis plant. Trichomes product the hundreds of known cannabinoids that can be found in cannabis. Of the 100+ cannabinoids that have been identified in the cannabis species, CBD and THC have been studied the most extensively for their role in the endocannabinoid system.
Cannabis oil and CBD have similarities but some important differences for users. Both are cannabinoids that can be found in all cannabis plants including hemp and marijuana. Cannabinoids are the substances secreted by the flowers of the cannabis plant and contain natural medicinal properties, offering relief from conditions including anxiety, pain, nausea, and inflammation.
The passing of SB 218 through the Kentucky legislature created a new subsection of KRS 260.850m to 260.289, in which the Industrial Hemp Advisory Board outlines the purpose of an industrial hemp research program, establish license provisions, and create new requirements and license application procedures. This state’s approach is for the potential medical and industrial applications.